(19)
(11) EP 2 213 297 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
28.01.2015 Bulletin 2015/05

(45) Mention of the grant of the patent:
17.12.2014 Bulletin 2014/51

(21) Application number: 10075018.1

(22) Date of filing: 08.03.2006
(51) International Patent Classification (IPC): 
A61K 39/07(2006.01)
A61K 39/395(2006.01)
C07K 14/31(2006.01)
 A61K 39/085(2006.01)
C07K 7/06(2006.01)

(54)

Staphylococcus aureus antigenic polypeptides

Staphylococcus aureus antigen Polypeptiden

Polypeptides antigéniques de staphylococcus aureus

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 23.03.2005 GB 0505949

(43) Date of publication of application:
04.08.2010 Bulletin 2010/31

(62) Application number of the earlier application in accordance with Art. 76 EPC:
06710041.2 / 1863525

(73) Proprietor: Absynth Biologics Limited
Liverpool Science Park, Innovation Centre 1 Liverpool L3 5TF (GB)

(72) Inventors:
  • Foster, Simon J.
    Hathersage West Yorkshire S32 1AW (GB)
  • Garcia Lara, Jorge
    Sheffield S6 3HJ (GB)

(74) Representative: Docherty, Robert Charles et al
Symbiosis IP Limited 106 Heworth Green
York YO31 7TQ
York YO31 7TQ (GB)


(56) References cited: : 
WO-A-00/13694
WO-A2-02/094868
 WO-A-01/70955
WO-A2-03/083099
   
  • DATABASE Geneseq [Online] 19 June 2003 (2003-06-19), Wang et al.: "Protein encoded by Prokaryotic essential gene 1761" XP002586213 retrieved from EBI Database accession no. ABU16234 & WO 02/077183 A (ELITRA PHARMACEUTICALS, INC; WANG, LIANGSU; ZAMUDIO, CARLOS; MALONE, C) 3 October 2002 (2002-10-03)
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).